HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bosentan is effective against digital ulcerations and hyperkeratosis in systemic sclerosis.

AuthorsZsuzsanna Kurgyis, Rita Varga, Isabell Sick, Martin Ulrich Lang, Thomas Ruzicka, Miklós Sárdy
JournalActa dermato-venereologica (Acta Derm Venereol) Vol. 91 Issue 6 Pg. 716-7 (Oct 2011) ISSN: 1651-2057 [Electronic] Sweden
PMID21879251 (Publication Type: Case Reports, Letter)
Chemical References
  • Antihypertensive Agents
  • Sulfonamides
  • Bosentan
Topics
  • Antihypertensive Agents (therapeutic use)
  • Bosentan
  • Female
  • Hand Dermatoses (drug therapy)
  • Humans
  • Keratosis (drug therapy, etiology)
  • Middle Aged
  • Raynaud Disease (complications)
  • Scleroderma, Systemic (complications)
  • Skin Ulcer (drug therapy, etiology)
  • Sulfonamides (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: